Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Why CoreWeave Stock Rocketed Higher Todayfool.com
Via The Motley Fool · April 1, 2025
Why Shares of Newsmax Are Up More Than 1,123% Since Its IPOfool.com
Via The Motley Fool · April 1, 2025
No Fooling - The Energy Reportcontent/com
U.S. oil demand is surging, hitting 20.736 million barrels a day which is up a whopping 5.9% a year ago.
Via Talk Markets · April 1, 2025
W.R. Berkley Nears Historical Price-To-Book High, Analyst Downgrades Stock On Overvaluation Concernsbenzinga.com
BofA Securities analyst downgraded W.R. Berkley to Neutral, citing limited upside despite strong fundamentals and a high price-to-book ratio.
Via Benzinga · April 1, 2025
Stocks Edge Higher Despite Trade, Economic Jitterstalkmarkets.com
Stocks are modestly higher Tuesday afternoon, as Wall Street shakes off a sluggish open amid a new wave of economic data.
Via Talk Markets · April 1, 2025
Why Shares of Axsome Therapeutics Slumped Todayfool.com
Via The Motley Fool · April 1, 2025
Alphabet Is A Massive Cash Flow Machine With An Under-Leveraged Balance Sheet: Analystbenzinga.com
WestPark Capital initiated coverage on Alphabet with a Buy rating and $210 price target. Despite missing Q4 estimates, Alphabet dominates the search market and has potential for growth in AI. Concerns about slowing growth in Google Cloud Platform and upcoming remedy trial.
Via Benzinga · April 1, 2025
Looking At Microsoft's Recent Unusual Options Activitybenzinga.com
Via Benzinga · April 1, 2025
FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticalsbenzinga.com
Apellis' Empaveli receives FDA Priority Review for rare kidney diseases C3G and IC-MPGN. Phase 3 data show strong efficacy in proteinuria reduction.
Via Benzinga · April 1, 2025
Dogecoin Whales Scoop 220 Million DOGE In March Despite 25% Drop: What Do They Know?benzinga.com
Dogecoin's (CRYPTO: DOGE) recent downturn appears to have attracted big buyers, as whale accumulation surged and traders predict a bullish breakout.
Via Benzinga · April 1, 2025
Assessing SiteOne Landscape Supply: Insights From 6 Financial Analystsbenzinga.com
Via Benzinga · April 1, 2025
The Analyst Verdict: Dow In The Eyes Of 9 Expertsbenzinga.com
Via Benzinga · April 1, 2025
Analyst Expectations For Gaming and Leisure Props's Futurebenzinga.com
Via Benzinga · April 1, 2025
Demystifying Spire Global: Insights From 8 Analyst Reviewsbenzinga.com
Via Benzinga · April 1, 2025
Demystifying Progress Software: Insights From 7 Analyst Reviewsbenzinga.com
Via Benzinga · April 1, 2025
Deep Dive Into Air Products & Chemicals Stock: Analyst Perspectives (9 Ratings)benzinga.com
Via Benzinga · April 1, 2025
Price Over Earnings Overview: Dutch Brosbenzinga.com
Via Benzinga · April 1, 2025
Small Cap Compass Therapeutics Shares Positive Primary Goal Data From Pivotal Cancer Drug Study For Biliary Tract Cancerbenzinga.com
Compass Therapeutics' Phase 2/3 trial shows tovecimig plus paclitaxel significantly improves response rates in advanced biliary tract cancer patients.
Via Benzinga · April 1, 2025
Tariffs Could Shake Building Industry: Homebuilders, Plumbing, Flooring Face Rising Costsbenzinga.com
BofA Securities sees headwinds for Masco and homebuilders but potential gains for Whirlpool.
Via Benzinga · April 1, 2025
Knight-Swift Faces Pressure With Lack Of Freight Flows Amid Tariffs, Analyst Downgrades Stockbenzinga.com
BofA Securities downgraded Knight-Swift Transportation to Neutral, slashing its price target from $66 to $46. The revision reflects valuation concerns and declining earnings forecasts due to freight slowdowns and tariff impacts.
Via Benzinga · April 1, 2025
Valaris Needs More Cost-Cutting To Hit 2025 EBITDA Target: Analystbenzinga.com
JP Morgan lowers price target to $38, and warns of the need for further cost-cutting to meet 2025 EBITDA guidance amid ongoing market challenges.
Via Benzinga · April 1, 2025
Apple Stock Looks Appetizing At Current Levels, Citi Saysinvestors.com
Investment bank Citi said Apple stock looks attractive as the consumer electronics giant expands the availability of Apple Intelligence.
Via Investor's Business Daily · April 1, 2025
Spotify Audiobooks, Ad Growth Drive Analyst Confidencebenzinga.com
Analyst maintains Buy rating on Spotify with $700 PT. Expects profitability & FCF growth, confident in 2025 results.
Via Benzinga · April 1, 2025
Ethereum Is Unfolding A Five-Wave Bearish Impulsetalkmarkets.com
Ethereum is unfolding a five-wave bearish impulse that can send the price lower from technical point of view and from Elliott Wave perspective.
Via Talk Markets · April 1, 2025
Is ASML Holding Gaining or Losing Market Support?benzinga.com
Via Benzinga · April 1, 2025